| Date Filed | Type | Description |
| 10/03/2023 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.71, valued at
$111.2
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 37,205 shares
@ $1.92, valued at
$71.4k
|
|
| 02/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
SC 13G
| KAZIMI A J reports a 38.3% stake in Cumberland Pharmaceuticals Inc. |
| 01/07/2022 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 18 shares
@ $4.14, valued at
$74.5
Bought 18 shares
@ $3.84, valued at
$69.1
Bought 18 shares
@ $4.47, valued at
$80.5
Bought 18 shares
@ $4.46, valued at
$80.3
Bought 18 shares
@ $5.61, valued at
$101
Bought 18 shares
@ $6.15, valued at
$110.7
Bought 18 shares
@ $5.81, valued at
$104.6
Bought 18 shares
@ $4.82, valued at
$86.8
Bought 30 shares
@ $4.36, valued at
$130.8
Bought 30 shares
@ $4.28, valued at
$128.4
Bought 30 shares
@ $4.29, valued at
$128.7 |
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2021 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 15 shares
@ $2.69, valued at
$40.4
Bought 15 shares
@ $2.87, valued at
$43.1
Bought 15 shares
@ $2.82, valued at
$42.3
Bought 15 shares
@ $2.76, valued at
$41.4
Bought 15 shares
@ $2.76, valued at
$41.4
Bought 15 shares
@ $2.84, valued at
$42.6
Bought 15 shares
@ $2.73, valued at
$41
Bought 15 shares
@ $2.71, valued at
$40.7
Bought 15 shares
@ $2.71, valued at
$40.7
Bought 15 shares
@ $2.81, valued at
$42.2
Bought 15 shares
@ $2.76, valued at
$41.4 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 37,209 shares
@ $3.53, valued at
$131.3k
Granted 100,000 shares
@ $3.56, valued at
$356k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2019 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 60 shares
@ $5.87, valued at
$352.2
Bought 60 shares
@ $5.86, valued at
$351.6
Bought 60 shares
@ $5.87, valued at
$352.2
Bought 60 shares
@ $5.83, valued at
$349.8
Bought 60 shares
@ $5.94, valued at
$356.4
Bought 120 shares
@ $6.15, valued at
$738
Bought 60 shares
@ $6.17, valued at
$370.2
Bought 60 shares
@ $6.07, valued at
$364.2
Bought 120 shares
@ $6.02, valued at
$722.4
Bought 60 shares
@ $5.91, valued at
$354.6
Bought 60 shares
@ $5.78, valued at
$346.8 |
|
| 07/26/2019 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 60 shares
@ $6.42, valued at
$385.2
Bought 60 shares
@ $6.37, valued at
$382.2
Bought 60 shares
@ $6.33, valued at
$379.8
Bought 60 shares
@ $6.36, valued at
$381.6
Bought 60 shares
@ $6.35, valued at
$381
Bought 60 shares
@ $6.33, valued at
$379.8
Bought 60 shares
@ $6.34, valued at
$380.4
Bought 60 shares
@ $6.54, valued at
$392.4
Bought 60 shares
@ $6.56, valued at
$393.6
Bought 60 shares
@ $6.54, valued at
$392.4
Bought 60 shares
@ $6.48, valued at
$388.8 |
|
| 06/14/2019 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 99 shares
@ $6.32, valued at
$625.7
Bought 81 shares
@ $6.21, valued at
$503
Bought 32 shares
@ $6.04, valued at
$193.3
Bought 24 shares
@ $6.17, valued at
$148.1
Bought 14 shares
@ $6.32, valued at
$88.5
Bought 27 shares
@ $6.37, valued at
$172
Bought 73 shares
@ $5.61, valued at
$409.5
Bought 42 shares
@ $6.29, valued at
$264.2
Bought 23 shares
@ $6.07, valued at
$139.6
Bought 58 shares
@ $6.35, valued at
$368.3
Bought 57 shares
@ $6.01, valued at
$342.6 |
|
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2019 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 100,000 shares
@ $5.98, valued at
$598k
Paid exercise price by delivering 46,623 shares
@ $5.62, valued at
$262k
|
|
| 08/31/2018 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Gifted 200,000 shares
@ $0 |
|
| 03/23/2018 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 100,000 shares
@ $6.7, valued at
$670k
Paid exercise price by delivering 24,373 shares
@ $6.7, valued at
$163.3k
|
|
| 12/22/2017 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Gifted 15,000 shares
@ $0 |
|
| 04/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2016 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,802 shares
@ $4.51, valued at
$17.1k
|
|
|